CETRAXAL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cetraxal, and when can generic versions of Cetraxal launch?
Cetraxal is a drug marketed by Key Therap and is included in one NDA.
The generic ingredient in CETRAXAL is ciprofloxacin hydrochloride. There are thirty-four drug master file entries for this compound. Fifty-six suppliers are listed for this compound. Additional details are available on the ciprofloxacin hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cetraxal
A generic version of CETRAXAL was approved as ciprofloxacin hydrochloride by RUBICON on June 9th, 2004.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CETRAXAL?
- What are the global sales for CETRAXAL?
- What is Average Wholesale Price for CETRAXAL?
Summary for CETRAXAL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 123 |
| Patent Applications: | 943 |
| What excipients (inactive ingredients) are in CETRAXAL? | CETRAXAL excipients list |
| DailyMed Link: | CETRAXAL at DailyMed |
Pharmacology for CETRAXAL
| Drug Class | Fluoroquinolone Antibacterial |
| Mechanism of Action | Cytochrome P450 1A2 Inhibitors |
US Patents and Regulatory Information for CETRAXAL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Key Therap | CETRAXAL | ciprofloxacin hydrochloride | SOLUTION/DROPS;OTIC | 021918-001 | May 1, 2009 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
